Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001604457-26-000007

Options or other derivatives

  • CEO acquired 1,236,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Walker Neal · CEO

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-02-02 Grant or award : show line 1 in the form Restricted Stock Units +274,800 274,800 D
2026-02-02 Grant or award : show line 2 in the form Employee Stock Option (Right to Buy) +961,700 961,700 D
Loading xslF345X05/form4-02062026_110224.xml…